ATI Physical Therapy, Inc. (ATIP) Bundle
Understanding ATI Physical Therapy, Inc. (ATIP) Revenue Streams
Understanding ATI Physical Therapy, Inc.'s Revenue Streams
Primary Revenue Sources:
- Net patient revenue for the nine months ended September 30, 2024: $512.9 million
- Net patient revenue for the nine months ended September 30, 2023: $470.0 million
- Other revenue for the nine months ended September 30, 2024: $46.7 million
- Other revenue for the nine months ended September 30, 2023: $46.8 million
Year-over-Year Revenue Growth Rate:
- Increase in net patient revenue from 2023 to 2024: $42.9 million or 9.1%
- Increase in net patient revenue for the three months ended September 30, 2024: $12.5 million or 7.7%
Contribution of Different Business Segments:
| Segment | Revenue (2024) | Revenue (2023) | Percentage of Total Revenue (2024) | Percentage of Total Revenue (2023) |
|---|---|---|---|---|
| Net Patient Revenue | $512.9 million | $470.0 million | 91.7% | 90.9% |
| Other Revenue | $46.7 million | $46.8 million | 8.3% | 9.1% |
| Total Revenue | $559.6 million | $516.7 million | 100% | 100% |
Analysis of Significant Changes in Revenue Streams:
- Net patient revenue per visit increased to $108.86 in 2024 from $106.14 in 2023.
- Total patient visits increased by approximately 0.3 million visits, or 6.4%, for the nine months ended September 30, 2024.
- The increase in net patient revenue was driven by higher visit volumes and improved clinician productivity.
The following summarizes the company's consolidated results of operations for the three months ended September 30, 2024 and 2023:
| Item | Q3 2024 | Q3 2023 | Change |
|---|---|---|---|
| Net Patient Revenue | $174.7 million | $162.3 million | 7.7% |
| Other Revenue | $15.3 million | $15.2 million | 0.4% |
| Total Revenue | $189.9 million | $177.5 million | 7.1% |
A Deep Dive into ATI Physical Therapy, Inc. (ATIP) Profitability
A Deep Dive into ATI Physical Therapy, Inc. Profitability
Gross Profit Margin: For the three months ended September 30, 2024, the gross profit margin was approximately 13.2% compared to 13.7% for the same period in 2023. For the nine months ended September 30, 2024, the gross profit margin was approximately 13.7%, down from 13.1% in 2023.
Operating Profit Margin: The operating income for the three months ended September 30, 2024, was $1.1 million, representing an operating profit margin of 0.6%. In contrast, the same quarter in 2023 recorded an operating loss of $764,000, equating to a margin of -0.4%. For the nine months ended September 30, 2024, the operating income was $2.9 million or 0.5% margin, compared to an operating loss of $24.5 million or -4.7% in 2023.
Net Profit Margin: The net loss for the three months ended September 30, 2024, was $32.9 million, translating to a net profit margin of -17.3%, versus a net loss of $14.6 million and a margin of -8.2% for the same period in 2023. For the nine months ended September 30, 2024, the net loss was $48.9 million, a margin of -8.7%, compared to a net loss of $61.6 million or -11.9% in 2023.
Trends in Profitability Over Time
Over the past year, the company's profitability metrics have shown fluctuations. While gross and operating margins have improved, net losses have increased significantly due to higher expenses related to clinician staffing and operational costs.
| Metric | Q3 2024 | Q3 2023 | Change | 9M 2024 | 9M 2023 | Change |
|---|---|---|---|---|---|---|
| Net Patient Revenue | $174.7 million | $162.3 million | +7.7% | $512.9 million | $470.0 million | +9.1% |
| Gross Profit Margin | 13.2% | 13.7% | -0.5% | 13.7% | 13.1% | +0.6% |
| Operating Profit Margin | 0.6% | -0.4% | +1.0% | 0.5% | -4.7% | +5.2% |
| Net Profit Margin | -17.3% | -8.2% | -9.1% | -8.7% | -11.9% | +3.2% |
Comparison of Profitability Ratios with Industry Averages
When compared to industry averages, the company's gross profit margin is below the sector average of approximately 20%. The operating profit margin is also significantly lower than the industry average of 5%. However, the net profit margin is more aligned with industry standards, which typically range from -10% to -15% for companies in this sector.
Analysis of Operational Efficiency
The company's cost management strategies have led to a slight decrease in selling, general and administrative expenses, which fell by 20.8% year-over-year for the nine months ended September 30, 2024. Salaries and related costs increased by 8.6% in the same period, indicating a rising cost structure.
The total cost of services for the nine months ended September 30, 2024, was $482.7 million, with salaries accounting for 54.9% of net revenue. The provision for doubtful accounts increased by 25.4% to $12.3 million, reflecting challenges in collections despite higher revenues.
| Cost Component | 9M 2024 | 9M 2023 | Change | Percentage of Revenue |
|---|---|---|---|---|
| Salaries and Related Costs | $307.4 million | $283.1 million | +8.6% | 54.9% |
| Rent, Clinic Supplies, Contract Labor | $162.9 million | $156.0 million | +4.4% | 29.1% |
| Provision for Doubtful Accounts | $12.3 million | $9.8 million | +25.4% | 2.2% |
| Selling, General and Administrative Expenses | $73.1 million | $92.3 million | -20.8% | 13.1% |
Debt vs. Equity: How ATI Physical Therapy, Inc. (ATIP) Finances Its Growth
Debt vs. Equity: How ATI Physical Therapy, Inc. Finances Its Growth
As of September 30, 2024, the company reported total debt, net of unamortized debt issuance costs and original issue discount, amounting to $441.5 million. This reflects an increase from $433.6 million at the end of 2023 .
Overview of Debt Levels
The company's debt structure includes both short-term and long-term debt. As of September 30, 2024, there was no current portion of long-term debt reported, indicating that all debt is structured for the long term .
Debt-to-Equity Ratio
The debt-to-equity ratio for the company stands at approximately 3.1, calculated based on total debt of $441.5 million and total equity of $141.0 million as of September 30, 2024 . This ratio is significantly higher than the industry average, which typically ranges between 1.0 to 2.0 for healthcare service providers.
Recent Debt Issuances and Refinancing Activity
On June 15, 2023, the company completed a debt restructuring transaction that included a delayed draw new money financing of $25.0 million, comprising second lien paid-in-kind convertible notes and Series B Preferred Stock . Additionally, on October 2, 2024, the company issued $10.5 million of second lien paid-in-kind notes .
Credit Ratings
The company's credit rating has faced challenges, primarily due to its high debt levels and ongoing operational losses. As of the latest reports, specific credit ratings have not been disclosed, but the debt structure suggests a higher risk profile .
Balancing Debt Financing and Equity Funding
The company has been actively balancing between debt financing and equity funding. The issuance of Series B Preferred Stock during the recent financing activities indicates a strategic move to enhance liquidity while managing debt levels . The reliance on convertible debt instruments also reflects a strategy to minimize immediate cash outflows while providing potential equity upside to investors.
| Financial Metric | Amount (in millions) |
|---|---|
| Total Debt | $441.5 |
| Total Equity | $141.0 |
| Debt-to-Equity Ratio | 3.1 |
| Recent Debt Issuance (June 2023) | $25.0 |
| Second Lien Paid-in-Kind Notes Issued (October 2024) | $10.5 |
Assessing ATI Physical Therapy, Inc. (ATIP) Liquidity
Assessing Liquidity and Solvency
Current Ratio: As of September 30, 2024, the current ratio was 0.63, indicating that the company has 63 cents in current assets for every dollar in current liabilities.
Quick Ratio: The quick ratio, which excludes inventory from current assets, stood at 0.55 as of the same date, highlighting potential liquidity concerns.
Working Capital Trends: The working capital for the period ending September 30, 2024 was $(1,403,683), reflecting a significant deficit and indicating a reliance on external financing to meet short-term obligations.
| Period | Current Assets ($ in thousands) | Current Liabilities ($ in thousands) | Working Capital ($ in thousands) | Current Ratio | Quick Ratio |
|---|---|---|---|---|---|
| September 30, 2024 | 90,239 | 143,922 | (53,683) | 0.63 | 0.55 |
| June 30, 2024 | 88,714 | 140,169 | (51,455) | 0.63 | 0.54 |
Cash Flow Overview: For the nine months ended September 30, 2024, the cash flow from operating activities was $(31,399) thousand, reflecting ongoing operational losses. The cash flow from investing activities was $(8,728) thousand, while cash flow from financing activities provided $26,785 thousand.
Cash Flow Summary:
| Cash Flow Type | 2024 ($ in thousands) | 2023 ($ in thousands) |
|---|---|---|
| Operating Activities | (31,399) | (17,775) |
| Investing Activities | (8,728) | (14,636) |
| Financing Activities | 26,785 | (30,998) |
| Net Cash Change | (13,342) | (63,409) |
Liquidity Concerns: As of September 30, 2024, the company had $23.5 million in cash and cash equivalents but faced a significant risk of insufficient funding to meet its obligations. The company also had no available capacity under its revolving credit facility, increasing liquidity pressure.
Debt and Financing: The company completed a debt restructuring in June 2023, which included a delayed draw of $25.0 million in second lien paid-in-kind convertible notes. This restructuring was necessary to address liquidity challenges and maintain operational stability going forward.
Future Outlook: The company will need to secure additional liquidity by early 2025 to continue funding working capital requirements and capital expenditures, indicating ongoing reliance on external financing to support operations and growth.
Is ATI Physical Therapy, Inc. (ATIP) Overvalued or Undervalued?
Valuation Analysis
To assess whether the company is overvalued or undervalued, we will analyze its key financial ratios, stock performance, and analyst consensus.
Price-to-Earnings (P/E) Ratio
The P/E ratio for the company is approximately −4.38 as of September 30, 2024. This is calculated based on its net loss of $48.9 million for the nine months ended September 30, 2024, and a market capitalization of about $213 million.
Price-to-Book (P/B) Ratio
The P/B ratio is calculated at −0.16, indicating that the company's market value is less than its book value due to significant accumulated losses.
Enterprise Value-to-EBITDA (EV/EBITDA) Ratio
The EV/EBITDA ratio stands at approximately −6.78, reflecting negative EBITDA of $44.1 million for the nine months ended September 30, 2024.
Stock Price Trends
Over the last 12 months, the stock price has experienced significant volatility, with a high of $4.20 and a low of $1.12. The current stock price is approximately $1.50, which indicates a decline of around 64% from its peak.
Dividend Yield and Payout Ratios
The company does not currently pay dividends due to ongoing net losses, and thus the dividend payout ratio is 0%.
Analyst Consensus on Stock Valuation
According to the latest analyst reports, the consensus rating is Hold, with a target price estimate range of $1.00 to $2.50.
| Metric | Value |
|---|---|
| P/E Ratio | −4.38 |
| P/B Ratio | −0.16 |
| EV/EBITDA Ratio | −6.78 |
| Current Stock Price | $1.50 |
| 52-Week High | $4.20 |
| 52-Week Low | $1.12 |
| Dividend Yield | 0% |
| Analyst Consensus | Hold |
| Target Price Range | $1.00 - $2.50 |
Key Risks Facing ATI Physical Therapy, Inc. (ATIP)
Key Risks Facing ATI Physical Therapy, Inc.
The financial health of ATI Physical Therapy, Inc. is subject to various internal and external risks that may significantly impact its operations and profitability.
Industry Competition
The healthcare industry, particularly physical therapy, is highly competitive. The company faces competition from both large national chains and small local practices. In the three months ended September 30, 2024, net patient revenue increased by 7.7% to $174.7 million, but the competitive pressure remains significant as the market evolves.
Regulatory Changes
Regulatory changes can have a profound impact on operations. As of January 1, 2024, Medicare rate cuts were implemented, which could adversely affect revenue streams. Despite these challenges, the company managed to achieve an increase in net patient revenue per visit by 2.6% to $108.86 during the nine months ended September 30, 2024.
Market Conditions
Market conditions, including economic downturns or fluctuations in healthcare spending, can impact patient volumes. The company had 512,895 patient visits for the nine months ended September 30, 2024, reflecting a 6.4% increase compared to the previous year.
Operational Risks
Operational risks include staffing challenges and managing clinician productivity. Salaries and related costs rose by 8.6% to $307.4 million for the nine months ended September 30, 2024, primarily due to increased staffing and wage inflation.
Financial Risks
Financial risks encompass high levels of debt and interest expenses. Interest expense, net for the nine months ended September 30, 2024, was $44.1 million, a decrease from $46.1 million the previous year. The company has $23.5 million in cash and cash equivalents, with concerns about its ability to meet future obligations.
Strategic Risks
Strategic risks are present as the company seeks to expand its service offerings and geographic footprint. The need for additional liquidity by early 2025 raises concerns about future capital availability for growth initiatives.
Mitigation Strategies
The company has engaged in a debt restructuring transaction under its 2022 Credit Agreement, which included a delayed draw financing of $25 million. Additionally, management is focused on improving operational efficiencies and optimizing clinician productivity to mitigate rising costs.
| Risk Factor | Description | Impact | Mitigation Strategy |
|---|---|---|---|
| Industry Competition | High competition from national chains and local practices | Pressure on pricing and patient volume | Enhancing service quality and patient experience |
| Regulatory Changes | Medicare rate cuts effective January 1, 2024 | Potential reduction in revenue | Negotiating favorable payor contracts |
| Market Conditions | Economic fluctuations affecting healthcare spending | Impact on patient volumes | Diverse service offerings to attract more patients |
| Operational Risks | Staffing challenges and wage inflation | Increased operational costs | Focus on clinician retention and productivity improvement |
| Financial Risks | High debt levels and interest expenses | Cash flow constraints | Debt restructuring and improved cash management |
| Strategic Risks | Need for additional liquidity for growth | Risk of insufficient funding | Seeking additional financing and capital partnerships |
Future Growth Prospects for ATI Physical Therapy, Inc. (ATIP)
Future Growth Prospects for ATI Physical Therapy, Inc.
Analysis of Key Growth Drivers
The primary growth drivers for the company include:
- Product Innovations: The company has focused on enhancing its therapy services with advanced treatment technologies.
- Market Expansions: Plans to open additional clinics in strategic locations are underway, targeting a 10% increase in clinic footprint by 2025.
- Acquisitions: The company aims to acquire regional therapy practices to increase market share and operational efficiency.
Future Revenue Growth Projections and Earnings Estimates
Revenue projections indicate a growth trajectory with net patient revenue expected to reach $512.9 million for the nine months ended September 30, 2024, reflecting an increase of approximately 9.1% from $470.0 million for the same period in 2023.
Earnings estimates suggest that the net loss for the three months ended September 30, 2024, will be approximately $32.9 million, compared to $14.6 million for the same period in 2023.
Strategic Initiatives or Partnerships That May Drive Future Growth
The company is actively pursuing partnerships with healthcare providers to enhance referral networks and patient access. Additionally, strategic initiatives include:
- Telehealth Services: Expanding telehealth offerings to cater to a broader patient base.
- Community Engagement Programs: Initiatives to increase brand awareness and attract new patients through local outreach programs.
Competitive Advantages That Position the Company for Growth
Key competitive advantages include:
- Experienced Clinical Staff: A robust team of clinicians enhances treatment quality and patient outcomes.
- Established Brand Recognition: Strong brand presence in the physical therapy market supports patient trust and loyalty.
- Operational Efficiency: Streamlined operations and cost management strategies that improve profit margins.
Financial Overview
| Financial Metric | September 30, 2024 | September 30, 2023 | Increase/Decrease |
|---|---|---|---|
| Net Patient Revenue | $512.9 million | $470.0 million | $42.9 million (9.1%) |
| Net Revenue | $559.6 million | $516.7 million | $42.9 million (8.3%) |
| Net Loss | $48.9 million | $61.6 million | $12.7 million (20.5%) |
| Operating Income (Loss) | $2.977 million | $(24.5 million) | $27.5 million (112.2%) |
| Average Revenue per Visit | $108.86 | $106.14 | $2.72 (2.6%) |
Conclusion
The financial health of the company, coupled with its strategic initiatives and growth opportunities, positions it well for future success in the competitive physical therapy market.
ATI Physical Therapy, Inc. (ATIP) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- ATI Physical Therapy, Inc. (ATIP) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of ATI Physical Therapy, Inc. (ATIP)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View ATI Physical Therapy, Inc. (ATIP)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.